Mastercard Board of Directors Announces Quarterly Dividend — Neutral

MA   Business Wire — February 10, 2025

PURCHASE, N.Y.--(BUSINESS WIRE)--Mastercard (NYSE: MA) announced that its Board of Directors has declared a quarterly cash dividend of 76 cents per share.

image for news Mastercard Board of Directors Announces Quarterly Dividend

Business combination materially improves scale and product scope, advancing Columbus McKinnon's strategy as the holistic provider of intelligent motion solutions in materials handling Complementary portfolio enhances strategic positioning in attractive verticals and target geographies, delivering an even stronger portfolio of products Transaction valued at approximately $2.7 billion at a ~8x TTM Adjusted EBITDA multiple post-synergies Expected to create ~$70 million in annual net cost synergies, improving Adjusted EBITDA Margins1 to greater than 23% and is expected to more than double revenue and triple Adjusted EBITDA1 on a pro-forma combined basis Significant combined cashflow generation expected to enable de-leveraging to Net …

image for news Columbus McKinnon to Combine with Kito Crosby Delivering Compelling Value Creation

MAYFIELD HEIGHTS, Ohio--(BUSINESS WIRE)--Materion Corporation (NYSE: MTRN) is scheduled to release its fourth quarter and full year 2024 financial results on February 19, 2025, before the opening of the New York Stock Exchange. The company will hold a conference call with investors at 10:00 AM ET that morning. Jugal Vijayvargiya, President and Chief Executive Officer, and Shelly Chadwick, Vice President, Finance and Chief Financial Officer, will represent Materion Corporation on the call. Confe.

image for news Materion Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results on February 19

Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Results — Neutral

MEDP   Business Wire — February 10, 2025

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Results Revenue for the three months ended December 31, 2024 increased 7.7% to $536.6 million, compared to $498.4 million for the comparable prior-year period. On a constant currency basis, revenue for the fourth quarter of 2024 increased 7.8% compared to the fourth quarter of 2023. Backlog as.

image for news Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Results

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today that the Company's management will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12th, 2025 at 11:20am Eastern Time. Investors and attendees that would like to schedule a meeting with DiaMedica's management can contact their Oppenheimer representative to a.

image for news DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

COLUMBUS, Ohio--(BUSINESS WIRE)--T. Marzetti Company, a wholly owned subsidiary of Lancaster Colony Corporation (NASDAQ: LANC), is proud to announce that two of its recently-launched items have been named Product of the Year for 2025. New York Bakery™ Gluten Free Texas Toast was awarded the top gluten-free item. Texas Roadhouse™ Mini Rolls were named top bakery side dish. Product of the Year USA is the world's largest consumer-voted award for marketplace innovation, voted on by 40,000 consumers.

image for news T. Marzetti Wins 2025 Product of the Year Awards for New York Bakery Gluten Free Texas Toast and Texas Roadhouse Mini Rolls

PAPI: One Active Strategy, Two Income Sources — Positive

PAPI  SPY   ETF Trends — February 10, 2025

Income investors seeking the potential benefits of an actively managed strategy this year should consider the Parametric Equity Premium Income ETF (PAPI). The fund combines dividends income with a systematic options writing strategy to generate income for investors.

image for news PAPI: One Active Strategy, Two Income Sources

BRIXMOR PROPERTY GROUP REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS — Neutral

BRX   PRNewsWire — February 10, 2025

- Continues to Leverage Strong Tenant Demand - NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Brixmor Property Group Inc. (NYSE: BRX) ("Brixmor" or the "Company") announced today its operating results for the three and twelve months ended December 31, 2024. For the three months ended December 31, 2024 and 2023, net income attributable to Brixmor Property Group, Inc. was $0.27 per diluted share and $0.24 per diluted share, respectively, and for the twelve months ended December 31, 2024 and 2023, net income attributable to Brixmor Property Group, Inc. was $1.11 per diluted share and $1.01 per diluted share, respectively.

image for news BRIXMOR PROPERTY GROUP REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

Devon Energy: Shares Washed Out And Undervalued Heading Into Earnings — Neutral

DVN   Seeking Alpha — February 10, 2025

Devon Energy is rated a buy due to its compelling valuation, despite a 25% decline since August 2024 and recent oil price drops. Q3 2024 results showed strong production and revenue growth, beating estimates, with significant free cash flow and shareholder returns via buybacks and dividends. Risks include a weaker global economy, lower oil prices, and potential delays in new upstream assets impacting EPS growth forecasts.

image for news Devon Energy: Shares Washed Out And Undervalued Heading Into Earnings

Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024

image for news Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook

3M Rises 21.5% in Six Months: Should You Buy the Stock Now or Wait? — Negative

MMM   Zacks Investment Research — February 10, 2025

MMM is making strides in the transportation, roofing granules and electrical markets, which makes the stock worth a watch amid certain headwinds.

image for news 3M Rises 21.5% in Six Months: Should You Buy the Stock Now or Wait?

BLK Trades Below 52-Week High: Buy the Stock Before it Soars Again? — Positive

BLK   Zacks Investment Research — February 10, 2025

BlackRock shares are presently trading 8.5% below its 52-week high. Does this represent an opportunity to buy?

image for news BLK Trades Below 52-Week High: Buy the Stock Before it Soars Again?

3 Transportation Stocks Positioned to Surpass Q4 Earnings Estimates — Positive

ACDVF  GLNG  VLRS   Zacks Investment Research — February 10, 2025

Transportation stocks like ACDVF, VLRS and GLNG have the potential to deliver better-than-expected fourth-quarter results.

image for news 3 Transportation Stocks Positioned to Surpass Q4 Earnings Estimates

BlackBerry Soars 39% Year to Date: Is the Stock Still a Buy? — Positive

BB   Zacks Investment Research — February 10, 2025

BB's improving financial performance, strategic initiatives/collaborations and focus on IoT and Secure Communications units position it for long-term growth.

image for news BlackBerry Soars 39% Year to Date: Is the Stock Still a Buy?

Tower Semiconductor Ltd. (TSEM) Q4 2024 Earnings Call Transcript — Neutral

TSEM   Seeking Alpha — February 10, 2025

Tower Semiconductor Ltd. (NASDAQ:TSEM ) Q4 2024 Earnings Conference Call February 10, 2024 10:00 AM ET Company Participants Noit Levi - Senior Vice President of Investor Relations and Corporate Communications Russell Ellwanger - Chief Executive Officer Oren Shirazi - Chief Financial Officer, Senior Vice President of Finance Conference Call Participants Cody Acree - Benchmark Bastien Faucon-Morin - SIG Richard Shannon - Craig Hallum Lisa Thompson - ZACKS Investment Research Matthew Bryson - Wedbush Operator Good day and thank you for standing by.

image for news Tower Semiconductor Ltd. (TSEM) Q4 2024 Earnings Call Transcript

SAN FRANCISCO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- HashiCorp, Inc. (NASDAQ: HCP), The Infrastructure Cloud™ company, today announced it will release financial results for the fourth quarter of its 2025 fiscal year, which ended January 31, 2025, after the U.S. markets close Thursday, March 6, 2025.

image for news HashiCorp to announce fourth quarter fiscal year 2025 financial results on March 6, 2025

Q4 Highlights: Revenue of $252.4 million Operating Margin of 21.6% Diluted earnings per share of $1.54 BEVERLY, Mass. , Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2024.

image for news Axcelis Announces Financial Results for Fourth Quarter and Full Year 2024

CHICAGO , Feb. 10, 2025 /PRNewswire/ -- Heidrick & Struggles International, Inc. (Nasdaq: HSII) ("Heidrick & Struggles", "Heidrick" or the "Company"), a premier provider of global leadership advisory and on-demand talent solutions, today announced it will host its quarterly conference call to discuss fourth quarter and full year 2024 financial results on Monday, March 3, 2025, at 5:00pm ET. The conference call and accompanying slides will be publicly available via live webcast on the investor relations section of the Heidrick & Struggles website at www.heidrick.com.

image for news Heidrick & Struggles to Release Fourth Quarter and Full Year 2024 Results

Prospect Capital Announces Financial Results for Fiscal December 2024 Quarter — Neutral

PSEC   GlobeNewsWire — February 10, 2025

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) today announced financial results for our fiscal quarter ended December 31, 2024.

image for news Prospect Capital Announces Financial Results for Fiscal December 2024 Quarter

Sera Prognostics Announces Proposed Public Offering — Neutral

SERA   PRNewsWire — February 10, 2025

SALT LAKE CITY , Feb. 10, 2025 /PRNewswire/ -- Sera Prognostics, Inc., The Pregnancy Company® ("Sera" or the "Company") (Nasdaq: SERA), which focuses on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it has commenced a proposed underwritten public offering of its Class A common stock and, in lieu of Class A common stock to certain investors, pre-funded warrants to purchase shares of its Class A common stock. In addition, Sera intends to grant the underwriters a 30-day option to purchase shares of Class A common stock in an amount …

image for news Sera Prognostics Announces Proposed Public Offering